Use access key #2 to skip to page content.
$0.33 -0.17 (-34.00%)
10/10/2008 3:50 PM

Hana Biosciences, Inc. (HNAB)

CAPS Rating:
No stars

A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.

View All Commentary (HNAB)

Recs

0

Avatar bioman100 (21.62) Submitted: 8/24/06 10:05 PM : Outperform Start Price: $7.38 HNAB Score: -63.83

prostate drug in development, oral navelbine, good pipeline.

Report this Post Replies: 0 | Reply

Featured Broker Partners